3 Likes
Aurobindo Pharma’s US FDA woes deepen.
Unit II in Bhiwadi gets ‘Official Action Indicated’ classification after inspection, raising concerns over regulatory compliance.
1 Like
Aurobindo Pharma’s board has approved buying back the entire 80% stake in Tergene Biotech from Auro Vaccines, its step-down subsidiary. After the deal, Tergene Biotech will become a direct subsidiary of Aurobindo Pharma.
The board has approved a deal to buy solar power from Swarnaaskshu Solar Power, a company being set up. As part of this, the company will acquire up to 26% stake in Swarnaaskshu under Telangana’s captive power policy.
2 Likes